Sign in

NCT05285631Completed

Early Prediction of ICD Candidacy After Anterior Myocardial Infarction

Source: ClinicalTrials.gov · Last updated 3 Jun 2026

Brief summary (registry, in English)

Despite the advances of pharmacologic and interventional therapies, sudden (or arrhythmic) cardiac death remains very high in the early weeks-to-months after an acute myocardial infarction (MI).The majority of cardiac arrests occur in patients who have large infarctions resulting in extensive myocardial damage, which is translated into lower left ventricular ejection fraction (LVEF). Hence, low LVEF remains -to the current time- the most robust predictor for post MI sudden (and presumably arrhythmic) death; and is the determinant for implantable cardioverter defibrillator (ICD) candidacy for primary prevention as per clinical practice guidelines.ICD significantly and effectively reduced ventricular arrhythmia (VA)-mediated cardiac deaths among these patients.

Status (registry)
Completed
Study type
Observational
Enrollment
200 (actual)
First submitted
11 Feb 2022
Start date
31 May 2022
Primary completion date
31 Dec 2025
Lead sponsor
Aswan University
NCT number
NCT05285631

What you commit to

  • Study type: Observational
  • Participants enrolled: 200
  • From 31 May 2022 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Lab values

  • ● Refusal to participate in the study.
    • Patients with existing ICD or pacemakers.
    • Qualifying ICD for secondary prevention.
    • Known to have LVEF ≤ 40% prior to the index MI.
    • Previous PCI to Left anterior Descending artery (LAD).
    • Previous or being scheduled for CABG within ≤ 3 months.
    • Known to have limited life expectancy (less than 1-year) prior to the index MI.
    • Pregnant or lactating women.

Who the study is looking for

  • Age between 18 and 80 years. Both genders are eligible.
    • Patients with diagnosis of an acute anterior STEMI and revascularized with successful primary percutaneous coronary intervention (PCI) within 24 hours.
    • LVEF \< 40 % assessed by Bi-plane Simpsons rule within 48 hour post PCI.

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Magdi Yacoub Foundation
Coordinator of this site? Confirm its status
AswānEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.